Word mark

Trademark: 'HEMONC' 
Bayer Pharma AG
European Community Trademark, no. 001784057, Word mark


On 31. 7. 2000 the community trademark application no. 001784057 was filed for HEMONC (Word mark) by Bayer Pharma AG before the OAMI.The goods and services in respect of which registration of the trademark was sought are in class 5. The current status of the trademark is application refused.

Status is 'Application refused'
The Community Trade Mark application has been rejected during the registration phase. The refusal may be based on formalities, classification, absolute grounds or relative grounds, i.e. as a result of an opposition.

Applied31. 7. 2000
Nice classes5


You can follow this trademark. You will receive an email, whenever we detect changes of the trademark filing.
This service is for free. You can unsubsribve whenever you want. More information.



Bayer Pharma AG
Müllerstr. 178
13353 Berlin


If you are the trademark owner and the data above are not correct, then please update them soon by clicking on Update address.

If you want to transfer the trademark to another owner, click on Transfer trademark.

You can transfer a trademark partially or completely to another owner. A partial transfer means that you can transfer a trademark in specific classes.

Still questions? Call us : 0049 (0) 89 6666 10 89


Hillena Einfeld
Müllerstr. 178
13353 Berlin


If the data above is not correct, then please choose Update.


Nice classes

5  Pharmaceutical products and health-care products.


Records history

21.10.2016 The current state is Application refused
Current state
14.5.2008 Registered
Proprietor - Change of name and address
11.9.2007 Published
Proprietor - Change of name and address
13.8.2007 Published
Proprietor - Change of name and address
12.11.2001 Registered
Representative - Change of name and professional address
24.7.2001 Registered
Representative - Replacement of representative
31.7.2000 Application
Application of the trademark 001784057 HEMONC

Further trademarks of the owner

TASC TransAtlantic Inter-Society Consensus on the Management of PAOD
SCHERING making medicine work